Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.30 -0.20 (-5.65%)
As of: Oct 20, 2026 · 12:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Common Stock Issued (2025)

Updated

Analysis

Apimeds Pharmaceuticals US (APUS) Common Stock Issued (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,154.60 Bn 1,123.18 Bn 19.71 Bn -
2 Johnson & Johnson 624.15 Bn 542.68 Bn 17.26 Bn 359.00 Mn
3 AbbVie 512.14 Bn 485.26 Bn 12.70 Bn -
4 Merck 365.44 Bn 319.81 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn -
6 Astrazeneca 261.41 Bn 235.09 Bn 12.86 Bn 6.00 Mn
7 Amgen 234.57 Bn 189.96 Bn 7.24 Bn -
8 Gilead Sciences 192.90 Bn 167.10 Bn 6.22 Bn 9.00 Mn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn -
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -323,319.00
Sep 30, 2025 323,319.00
API Access

Apimeds Pharmaceuticals US Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=APUS&period=max&api_key=YOUR_API_KEY